AG
Artal Group Portfolio holdings
AUM
$930M
This Quarter Return
-7.28%
1 Year Return
-3.57%
3 Year Return
+157.23%
5 Year Return
+160.22%
10 Year Return
+1,359.85%
AUM
$2.09B
AUM Growth
+$2.09B
(-13%)
Cap. Flow
+$264M
Cap. Flow
% of AUM
12.61%
Top 10 Holdings %
Top 10 Hldgs %
53.53%
Holding
115
New
19
Increased
31
Reduced
8
Closed
12
Top Buys
| 1 |
uniQure
QURE
|
$54.6M |
| 2 |
Black Diamond Therapeutics
BDTX
|
$42.3M |
| 3 |
Schrodinger
SDGR
|
$38.7M |
| 4 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$27M |
| 5 |
PayPal
PYPL
|
$23M |
Top Sells
| 1 |
Moderna
MRNA
|
$48.1M |
| 2 |
BioNTech
BNTX
|
$23.4M |
| 3 |
Xencor
XNCR
|
$18.9M |
| 4 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$11M |
| 5 |
RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
|
$10.2M |
Sector Composition
| 1 | Healthcare | 78.33% |
| 2 | Consumer Discretionary | 16.23% |
| 3 | Financials | 2.02% |
| 4 | Technology | 1.61% |
| 5 | Communication Services | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
WW
1
DELISTED
WW International
WW
| $251M | 10.59% | 14,818,300 | – | – |
|
|
XLRN
2
DELISTED
Acceleron Pharma Inc.
XLRN
| $135M | 5.7% | 1,500,000 +300,000 | +25% | +$27M |
|
|
3
BioNTech
BNTX
$24B
| $130M | 5.5% | 2,228,130 -400,000 | -15% | -$23.4M |
|
4
Alnylam Pharmaceuticals
ALNY
$58.5B
| $120M | 5.06% | 1,100,000 +100,000 | +10% | +$10.9M |
|
5
Lexicon Pharmaceuticals
LXRX
$400M
| $117M | 4.96% | 60,240,864 | – | – |
|
|
6
Moderna
MRNA
$9.37B
| $89.9M | 3.8% | 3,000,000 -1,606,298 | -35% | -$48.1M |
|
|
ONC
7
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $80M | 3.38% | 650,000 +10,000 | +2% | +$1.23M |
|
8
Alibaba
BABA
$322B
| $77.8M | 3.29% | 400,000 -50,000 | -11% | -$9.72M |
|
9
argenx
ARGX
$43.6B
| $62.6M | 2.64% | 475,000 +125,000 | +36% | +$16.5M |
|
10
Avantor
AVTR
$9.18B
| $56.2M | 2.38% | 4,500,000 -250,000 | -5% | -$3.12M |
|
|
11
uniQure
QURE
$896M
| $54.6M | 2.31% | +1,150,000 | New | +$54.6M |
|
12
Fate Therapeutics
FATE
$120M
| $46.6M | 1.97% | 2,100,000 +100,000 | +5% | +$2.22M |
|
13
Amicus Therapeutics
FOLD
$2.34B
| $46.2M | 1.95% | 5,000,000 +2,000,000 | +67% | +$18.5M |
|
|
14
Black Diamond Therapeutics
BDTX
$157M
| $42.3M | 1.79% | +1,696,517 | New | +$42.3M |
|
|
15
PayPal
PYPL
$67.1B
| $42.1M | 1.78% | 440,000 +240,000 | +120% | +$23M |
|
|
16
Schrodinger
SDGR
$1.44B
| $38.7M | 1.64% | +897,445 | New | +$38.7M |
|
|
EPZM
17
DELISTED
Epizyme, Inc
EPZM
| $35.7M | 1.51% | 2,300,000 +50,000 | +2% | +$776K |
|
|
DCPH
18
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $32.9M | 1.39% | 800,000 +550,000 | +220% | +$22.6M |
|
19
Zillow
Z
$20.4B
| $32.4M | 1.37% | 900,000 +150,000 | +20% | +$5.4M |
|
20
Scholar Rock
SRRK
$3.14B
| $30.8M | 1.3% | 2,546,040 | – | – |
|
|
MORF
21
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $26.7M | 1.13% | 1,819,186 | – | – |
|
|
BPMC
22
DELISTED
Blueprint Medicines
BPMC
| $23.4M | 0.99% | 400,000 | – | – |
|
23
Iovance Biotherapeutics
IOVA
$807M
| $22.5M | 0.95% | 750,000 +250,000 | +50% | +$7.48M |
|
24
Atara Biotherapeutics
ATRA
$84.6M
| $21.3M | 0.9% | 2,500,000 +750,000 | +43% | +$6.38M |
|
25
FibroGen
FGEN
$47.8M
| $20.9M | 0.88% | 600,000 +200,000 | +50% | +$6.95M |
|